Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study.
Gatske M Nieuwenhuyzen-de BoerMalika KengsakulIngrid A BoereH Lena C van DoornHeleen van BeekhuizenPublished in: Cancers (2022)
This study indicated a two-year survival of 15%. Optimal treatment strategies in terms of survival benefits are still ill-defined. Further study of this specific group of patients is warranted. We advocate an (inter)national registry of patients with unresectable cancer and comprehensive follow-up.